tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dominic Lunn, 6 are a HOLD (33.33%), 5 are a SELL (27.78%), 7 are a BUY (38.89%).
Analyst Dominic Lunn, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 64.29% that have a potential upside of 18.7% achieved within 411 days.
Dominic Lunn’s has documented 35 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 26-Apr-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2022. The price target of $57.55 was fulfilled within 35 days with a profit of $6.01 (11.66%) receiving and performance score of 3.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Dec-2015
$20.57
2 months 9 days ago
(24-Jul-2026)
2/3 (66.67%)
$-11.56 (-35.98%)
4036
Hold Since 06-Jan-2026
8 months 27 days ago
(06-Jan-2026)
0/13 (0%)
$-14.35 (-43.95%)
Sell Since 03-Jan-2023
$17.1
9 months 23 days ago
(10-Dec-2025)
0/2 (0%)
$-13.25 (-43.66%)
Hold Since 06-Feb-2025
10 months 21 days ago
(12-Nov-2025)
0/11 (0%)
$-12.38 (-34.45%)
Hold Since 06-Sep-2025
$45
$-2.03 (-4.32%)
1 years 27 days ago
(06-Sep-2025)
3/3 (100%)
$5.89 (15.06%)
1661
What Year was the first public recommendation made by Dominic Lunn?
